I have had 12 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
u/arne_nyberg
Contributes reviews on supplier material. Based in Dhaka.
member · joined 12 Mar 2025
Overview — page 3 of 5
comment on someone explain vendor to me like I have not read a paper in years in c/vendorvetting · 63 points · 7 months ago
Cosigning the evidence standard. Receipts make the community.
comment on [Lab] 24th independent test on QSC, and the trend is the interesting part in c/hplc · 113 points · 8 months ago
Small correction: the trial was 3 weeks, not 12. Does not change your point but people will quote it.
comment on testing — 12 things I got wrong before I got it right in c/vendorvetting · 18 points · 8 months ago
Cosigning the evidence standard. Receipts make the community.
comment on [Discussion] the T2D advice in here is 19 years out of date in c/t2dglp1 · 8 points · 8 months ago
Slight fix: the number was 95.1, not 94.2.
Disagree on that part. 98.1% and 98.3% on the same vial is normal.
comment on 15 months in and purity is still the thing I get wrong in c/hplc · 198 points · 9 months ago
chromatogram or it did not happen
comment on what would you tell week-1 you about Medutest in c/vendorvetting · 105 points · 9 months ago
Yeah, WXT took 24 days and the material was flawless. Both of those things are true.
comment on 15 months in and purity is still the thing I get wrong in c/hplc · 137 points · 9 months ago
The related substances profile is way more interesting than the main peak %. A 98% with 17 peaks is different from a 98% that is one 35% impurity.
comment on 15 months in and purity is still the thing I get wrong in c/hplc · 88 points · 9 months ago
The PeptideMeter result being close to my own HPLC is the signal, not the absolute number. Both are right.
chromatogram. That is the whole post, but I will justify it. Everything else people worry about in c/reconstitution is downstream of it. Titration speed, muscle cramps,…
comment on unpopular opinion: pricing is massively overrated in c/glp1uk · 155 points · 9 months ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on small win: chromatogram stopped being a problem at week 95 in c/hplc · 35 points · 10 months ago
What was the column and what gradient?
comment on small win: glycaemic control stopped being a problem at week 30 in c/t2dglp1 · 444 points · 11 months ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on 21 months in and HPLC is still the thing I get wrong in c/hplc · 690 points · 11 months ago
integration decision on a shoulder changes your number by half a point on its own
comment on my TSH moved and I cannot work out whether pricing is why in c/glp1uk · 1 points · 11 months ago
price posts need the date — UK pricing moves monthly
comment on does purity actually matter or is it forum lore at this point in c/hplc · 11 points · 11 months ago
co-elution is real and LC-MS is usually not enough to resolve it
comment on why does nobody talk about VendorInvestigate in c/vendorvetting · 8 points · 11 months ago
positive and negative reports both need the same evidence standard
comment on does CGM actually matter or is it forum lore at this point in c/t2dglp1 · 15 points · 12 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on does CGM actually matter or is it forum lore at this point in c/t2dglp1 · 147 points · 1 year ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on week 16 check-in — 37kg down, early fullness manageable, one thing confusing me in c/hplc · 1 points · 1 year ago
A shoulder on the main peak that 15 analysts integrated 9 different ways. Same trace, 98.9 spread.